Related Experiment Video
Updated: Jun 21, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
Published on: October 6, 2022
Heartmate XVE destination therapy for end-stage heart failure in a patient with human immunodeficiency virus
Syed Mehmood1, Danielle Blais, Stanley Martin
1Division of Cardiothoracic Surgery, Richard M. Ross Heart Hospital, The Ohio State University Medical Center, Columbus, OH 43210, USA.
Abstract:
Cardiac dysfunction is a known predictor of survival in patients with acquired immunodeficiency syndrome. In this report, we describe a human immunodeficiency virus (HIV)-infected patient with worsening heart failure who was managed successfully for 16 months with placement of a left ventricular assist device.
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Heart Failure V: Medical Management
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Heart Failure III: Clinical Manifestations
Heart Failure II: Pathophysiology

